Clinical Trial Update: Oral Type I Collagen for Relieving Scleroderma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating oral type I collagen for systemic sclerosis (scleroderma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease
• Systemic Sclerosis

Drugs mentioned

• Oral Type I Collagen (collagen type I)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Scleroderma, Connective Tissue Diseases | Phase 2 | Status: COMPLETED